Tag Archives: Oxycontin

FDA Finalizes New Mandatory Opioid Addiction Risk Label Warnings

December 21, 2023 By: Martha Garcia

New opioid addiction warnings are designed to help doctors and patients make better decisions about what to prescribe for pain management.
ISMP Releases Targeted Medication Safety Best Practices for Hospitals

February 14, 2022 By: Russell Maas

ISMP reports errors involving drug names are a common medication mistake, which could be addressed by a greater reliance on barcodes.
Johnson & Johnson Opioid Settlement May Provide $5B For States and Cities Nationwide

October 14, 2020 By: Irvin Jackson
Lawsuit Indicates Prenatal Opioid Exposure Resulted In Severe Withdrawal Symptoms, Developmental Impacts

July 15, 2020 By: Irvin Jackson
Johnson & Johnson Settles Lawsuits Over Opioid Crisis Brought By Ohio Counties

October 02, 2019 By: Irvin Jackson
OxyContin Maker Purdue Pharma Reaches Opioid Epidemic Settlement With Some States, Cities

September 12, 2019 By: Irvin Jackson
Opioid Crisis Settlement Structure Proposed To Resolve Thousands of Claims Nationwide

June 18, 2019 By: Austin Kirk
Opioid Settlement Results in Agreement to Pay $270M to State of Oklahoma By Makers of Oxycontin

March 27, 2019 By: Irvin Jackson
Oxycontin Addiction Risks Withheld by Drug Maker, Who “Created Manmade Disaster”: Lawsuit

January 17, 2019 By: Irvin Jackson
Lawsuits Over Opioid-Addicted Infants Will Not Be Consolidated in Separate MDL

December 10, 2018 By: Irvin Jackson

Philips CPAP Injury Lawsuits To Be Selected For Potential Bellwether Trials in October 2024 (Posted 3 days ago)

A scheduling order issued by a federal judge calls for parties to have a plan to select potential Philips CPAP injury lawsuit bellwether selections by the end of October.

Lawsuits Over Ozempic, Wegovy, Mounjaro and Other GLP1-RA Drugs May Hinge on Label Warnings (Posted 6 days ago)

Parties involved in GLP-1 RA injury lawsuits have filed position papers staking out their arguments over the adequacy of Ozempic, Mounjaro and Wegovy label warnings.

MDL Judge Dismisses Four Paraquat Bellwether Cases, After Excluding Plaintiffs' Expert Witness From Testifying at Trial (Posted 7 days ago)

A federal judge has dismissed four Paraquat bellwether trial cases after rejecting expert witness testimony necessary to establish that their Parkinson's disease was caused by the controversial weed killer.

Tag Archives: Oxycontin

FDA Finalizes New Mandatory Opioid Addiction Risk Label Warnings

ISMP Releases Targeted Medication Safety Best Practices for Hospitals

Johnson & Johnson Opioid Settlement May Provide $5B For States and Cities Nationwide

Lawsuit Indicates Prenatal Opioid Exposure Resulted In Severe Withdrawal Symptoms, Developmental Impacts

Johnson & Johnson Settles Lawsuits Over Opioid Crisis Brought By Ohio Counties

OxyContin Maker Purdue Pharma Reaches Opioid Epidemic Settlement With Some States, Cities

Opioid Crisis Settlement Structure Proposed To Resolve Thousands of Claims Nationwide

Opioid Settlement Results in Agreement to Pay $270M to State of Oklahoma By Makers of Oxycontin

Oxycontin Addiction Risks Withheld by Drug Maker, Who “Created Manmade Disaster”: Lawsuit

Lawsuits Over Opioid-Addicted Infants Will Not Be Consolidated in Separate MDL

More Top Stories

Review A Case